Cargando…
ICAT promotes colorectal cancer metastasis via binding to JUP and activating the NF‐κB signaling pathway
BACKGROUND: The inhibitor of β‐catenin and T‐cell factor (ICAT) is a direct negative regulator of the canonical Wnt signaling pathway, which is an attractive therapeutic target for colorectal cancer (CRC). Accumulating evidence suggests that ICAT interacts with other proteins to exert additional fun...
Autores principales: | Wang, Zihan, Hu, Jiancong, Chen, Junxiong, Zhang, Jingdan, Li, Weiqian, Tian, Yu, Liu, Huanliang, Yang, Xiangling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9551128/ https://www.ncbi.nlm.nih.gov/pubmed/36036768 http://dx.doi.org/10.1002/jcla.24678 |
Ejemplares similares
-
Overexpression of ICAT Inhibits the Progression of Colorectal Cancer by Binding with β-Catenin in the Cytoplasm
por: Hu, Jiancong, et al.
Publicado: (2021) -
Circular RNA GLIS2 promotes colorectal cancer cell motility via activation of the NF-κB pathway
por: Chen, Junxiong, et al.
Publicado: (2020) -
Jun-APOE-LRP1 axis promotes tumor metastasis in colorectal cancer
por: He, Lingyuan, et al.
Publicado: (2023) -
Exosomal transfer of p-STAT3 promotes acquired 5-FU resistance in colorectal cancer cells
por: Zhang, Qian, et al.
Publicado: (2019) -
Improved diagnostic value by combining plasma PON1 level with tumor biomarkers in Colorectal Cancer patients
por: Zhang, Jingdan, et al.
Publicado: (2020)